Potential long-term toxicity of repeated orally administered doses of artemether in rats

American Journal of Tropical Medicine and Hygiene

Volumn 66, Issue 1, 2002, Pages 30-34

  Shuhua, Xiao ^a   Yuanqing, Yang ^a   Qiqing, You ^a   Utzinger, Jürg ^a   Huifang, Guo ^a   Peiying, Jiao ^a   Jinying, Mei ^a   Jian, Guo ^a   Bergquist, Robert ^a   Tanner, Marcel ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER;

ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; ELECTROCARDIOGRAM; FEMALE; HISTOPATHOLOGY; KIDNEY FUNCTION; LIVER FUNCTION; LONG TERM EXPOSURE; MALARIA; MALE; NEUROTOXICITY; NONHUMAN; RAT; RETICULOCYTE COUNT; SCHISTOSOMIASIS; TOXICITY TESTING;

ANIMALIA; SCHISTOSOMA;

EID: 0036301733     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.66.30     Document Type: Article

References (29)

1. Artemisinin derivatives for treating severe malaria
2. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives
3. Fatal neurotoxicity of arteether and artemether
4. Neurotoxicity in animals due to arteether and artemether
5. Artemisinin neurotoxicity: Neuropathology in rats and mechanistic studies in vitro
6. Arteether: Risks of two-week administration in Macaca mulatta
7. Dose-dependent brainstem neuropathology following repeated arteether administration in rats
8. Acute high dose arteether toxicity in rats
9. Arteether toxicokinetics and pharmacokinetics in rats after 25 mg/kg/day single and multiple doses
10. Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats
11. Arteether-induced brain injury in Macaca mulatta. I. The precerebellar nuclei: The lateral reticular nuclei, paramedian reticular nuclei, and perihypoglossal nuclei
12. Neurotoxicity and artemisinin compounds: Do the observations in animals justify limitation of clinical use?
13. Experimental studies on early treatment of schistosomal infection with artemether
14. Preventive effect of artemether in rabbits infected with Schistosoma japonicum cercariae
15. Preventive effect of artemether in experimental animals infected with Schistosoma mansoni
16. Effect of artemether against Schistosoma haematobium in experimentally infected hamsters
17. The prophylactic effects of artemether against Schistosoma japonicum infections
18. Oral artemether for prevention of Schistosoma mansoni infection: Randomised controlled trial
19. The potential of artemether for the control of schistosomiasis
20. Tegument changes of Schistosoma japonicum and Schistosoma mansoni in mice treated with artemether
21. Artemether administered together with haemin damages schistosomes in vitro
22. Tegumental changes in 21-day-old Schistosoma mansoni harboured in mice treated with artemether
23. Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice
24. Pharmacokinetics of oral artemether in Thai patients with uncomplicated falciparum malaria
25. Pharmacokinetics of oral artesunate in Thai patients with uncomplicated falciparum malaria
26. The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats
27. The pharmacokinetics of artemisinin after administration of two different suppositories to healthy Vietnamese subjects
28. Observation on the effect of oral artemether on controlling schistosomiasis in Yunnan mountainous endemic area